dc.contributor.author |
Gazizov A.S. |
|
dc.contributor.author |
Smolobochkin A.V. |
|
dc.contributor.author |
Kuznetsova E.A. |
|
dc.contributor.author |
Abdullaeva D.S. |
|
dc.contributor.author |
Burilov A.R. |
|
dc.contributor.author |
Pudovik M.A. |
|
dc.contributor.author |
Voloshina A.D. |
|
dc.contributor.author |
Syakaev V.V. |
|
dc.contributor.author |
Lyubina A.P. |
|
dc.contributor.author |
Amerhanova S.K. |
|
dc.contributor.author |
Voronina J.K. |
|
dc.date.accessioned |
2022-02-09T20:45:04Z |
|
dc.date.available |
2022-02-09T20:45:04Z |
|
dc.date.issued |
2021 |
|
dc.identifier.uri |
https://dspace.kpfu.ru/xmlui/handle/net/170024 |
|
dc.description.abstract |
A series of novel 4-(het)arylimidazoldin-2-ones were obtained by the acid-catalyzed reaction of (2,2-diethoxyethyl)ureas with aromatic and heterocyclic C-nucleophiles. The proposed approach to substituted imidazolidinones benefits from excellent regioselectivity, readily available starting materials and a simple procedure. The regioselectivity of the reaction was rationalized by quantum chemistry calculations and control experiments. The anti-cancer activity of the obtained compounds was tested in vitro. |
|
dc.subject |
Anti-cancer activity |
|
dc.subject |
Anti-tumor activity |
|
dc.subject |
Cyclization |
|
dc.subject |
Cytotoxicity |
|
dc.subject |
Imidazolidine-2-one |
|
dc.subject |
Regioselectivity |
|
dc.subject |
Urea |
|
dc.title |
The highly regioselective synthesis of novel imidazolidin-2-ones via the intramolecular cyclization/electrophilic substitution of urea derivatives and the evaluation of their anticancer activity |
|
dc.type |
Article |
|
dc.relation.ispartofseries-issue |
15 |
|
dc.relation.ispartofseries-volume |
26 |
|
dc.collection |
Публикации сотрудников КФУ |
|
dc.source.id |
SCOPUS-2021-26-15-SID85111470855 |
|